跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
KINPEYGO 4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA
Approved
STANDARD
KINPEYGO 4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA
Stada Arzneimittel Ag
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 14, 2022
Approval ID
be65240cd29d8c25
Company
Stada Arzneimittel Ag
Type
Standard
Approval Details
Approval Id
be65240cd29d8c25
Drug Cima Aemps Name
KINPEYGO 4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA
Register Number
1221657001
Holder Company Name
Stada Arzneimittel Ag
Marketing Company Name
Laboratorio Stada S.L.
Holder Company Detail Path
/organization/stada-arzneimittel-ag
Authorization Date
2022-10-14
Dosage Form
CÁPSULA DURA DE LIBERACIÓN MODIFICADA
Dose
4 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Stada Arzneimittel Ag
Company Detail Path
/organization/stada-arzneimittel-ag
Company Information
Pharmaceutical Company Name
STADA Arzneimittel AG
Country Name
Germany
Website
http://www.stada.com
Active Ingredients
BUDESONIDA
4 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 14, 2022
Approval ID
be65240cd29d8c25
Type
Standard
Back to CIMA-AEMPS Approvals
KINPEYGO 4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA - CIMA-AEMPS Drug Approval Details
